Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 113
Selected: 0
NCT IDTitle
NCT00193934Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer
NCT05182931A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
NCT00418210Accelerated Partial Breast Irradiation for Early Breast Cancer
NCT04769817ProsTIC Registry of Men Treated With PSMA Theranostics
NCT01488565A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
NCT03363867BEACON - ABC in Recurrent Platinum Resistant HGSOC
NCT04918810Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT04914741A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
NCT03464942Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
NCT00431990A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
NCT06279260National Robotics-Assisted Radical Prostatectomy Database
NCT06127654Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
NCT04641013Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE)
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT04534725COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;
NCT05184790LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
NCT03851146A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours
NCT00753727Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma
NCT04985721A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
NCT03980171Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
NCT05169177Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT03161756Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
NCT06882499Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II
NCT05340374Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
NCT00482261A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
NCT05899985Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
NCT03307759Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
NCT07387978A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation Treatment
NCT03429387PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
NCT06414148MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
NCT06812715Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
NCT04343885In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
NCT02506556Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
NCT06105411Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT00434239Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
NCT01755650Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
NCT05053854PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
NCT07051525Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever
NCT04739670Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
NCT02385214MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT07434180Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
NCT04619147Invasive Fungal Infections in Patients Following Stem Cell Transplant
NCT06631872Implementing Surgery School Prehabilitation Using Telehealth
NCT02662062Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
NCT06480396High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma
NCT03287427MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
NCT07138222IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
NCT07090369Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
NCT01676428A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases
NCT00377195Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma